SETHAWUD CHAIKITGOSIYAKUL

Architected comprehensive infrastructure and workflow blueprints for multiple greenfield wellness centers, ensuring optimal patient flow and unidirectional molecular workflows compliant with WHO and ISO standards.

Developed comprehensive CAPEX/OPEX financial models guiding multi-million THB investment decisions, delivering projected ROI analyses and break-even timelines that secured stakeholder capital.

Engineered a proprietary, turnkey Quality Management System (QMS) suite comprising 200+ standardized assets (SOPs, Work Instructions, Forms). This intellectual property accelerates client readiness for ISO 15189 accreditation, reducing audit preparation timelines by approximately 40%.

Partnered with Chulalongkorn University researchers to optimize experimental designs and data analysis pipelines, enhancing data integrity for high-impact scientific publications.

Identified VAR2CSA mRNA transcription in 30.4% of non-pregnant patients, significantly challenging prevailing scientific paradigms and informing future vaccine targets.

Authored Q1 publication in The American Journal of Tropical Medicine and Hygiene (2024) on var2csa transcription and CNV.

Expertly utilized full-length/Sanger sequencing, qPCR, and RT-PCR with advanced phylogenetic analysis (MEGA/BioEdit).

Developed a 5-year business plan and investor-ready model, achieving a $6.27M valuation with projected $144M Year 5 revenue and 480% ROI.

Drove market entry through SWOT analysis and a B2B go-to-market strategy, targeting 75% hospital networks and 18% private clinics.

Defined the operating model for high-complexity genetics (NGS, dPCR, advanced clinical testing) and curated a portfolio including PGx (31 genes/298 drugs), 72-gene lung panel, and BRCA1/2.

Engineered a cost-effective, high-throughput, regulation-ready service model, improving access and affordability of genetic testing.

Managed end-to-end lifecycle for surgical/diagnostic instruments, enhancing adoption and satisfaction through technical support and sales training.

Expanded general laboratory operations, increasing overall capacity by 65% and growing the test menu from 120 to 185 assays.

Launched and commercialized new molecular diagnostics services, increasing test volume by 35% within the first quarter.

Developed the company's first DTC genetics offering, including at-home collection kits and telemedicine.

Formed premium international genetic-testing referral partnerships with CeGaT (Germany) and Novogenia (Austria), establishing efficient out-lab testing workflows and sample tracking.

Reduced reagent costs by up to 70% for SARS-CoV-2 and HPV DNA through strategic supplier re-negotiation and alternative validation.

Achieved ISO 15189 and ISO 15190 accreditation within one year by authoring 100+ SOPs and implementing a rigorous Quality Management System (QMS).

Established a molecular diagnostics lab with scalable workflows and robust biosafety measures, securing Department of Medical Sciences certifications for HPV DNA and SARS-CoV-2 testing.

Implemented LIMS, reducing report generation time by 98% (from 86 to 1.3 mins) and data entry errors by 83%.

Managed P&L and daily operations for 10,000+ tests/year, supervising a 20+ member laboratory team and ensuring quality workflows.

Oversaw diagnostic throughput for 12,000+ clients annually, ensuring 100% regulatory compliance and strict adherence to safety protocols for high-sensitivity HIV/STI testing.

Spearheaded the end-to-end establishment of the RSAT Nakhon Sawan Medical Technology Clinic, managing facility design, procurement, talent acquisition, and licensing to achieve full operational readiness.

Orchestrated QA initiatives for the Ramkhamhaeng branch, implementing foundational QMS frameworks to achieve readiness for Laboratory Accreditation (LA) standards.

Performed high-volume clinical laboratory tests and phlebotomy with strict QA/QC, ensuring prompt and precise diagnostic results for patient care and clinical decisions.

Co-developed the syllabus and laboratory manuals for Medical Parasitology and Techniques in Medical Parasitology.

Delivered didactic lectures and supervised wet-lab practicums for undergraduate Medical Technology students, focusing on the identification of helminths and protozoa in clinical specimens.

Conducted quantitative histomorphometric analysis of placental biopsies using ImageJ and Immunohistochemistry (IHC).

Generated publication-grade datasets characterizing malaria pathology across spleen, liver, brain, and placenta, contributing to mechanistic insights into Intrauterine Growth Restriction (IUGR).

Developed quality documents for HIV/STI diagnostics and trained staff to ensure accuracy and confidentiality.

Founded and managed the “HIV on Click” outreach platform, reaching 3,000+ individuals nationwide.

Provided telemedicine counseling, testing coordination, result communication, and referral support to nearly 1,000 clients through online and in-person services.

Strengthened NGO and healthcare center collaboration to improve access, continuity of care, and early linkage-to-treatment.